54th annual symposium
Ottawa, ON
November 30 – December 2, 2022
Environmental and Lifestyle Exposure to Endocrine Disrupting Chemicals: From Cells to Society
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
upcoming event
More infoHybrid event for in-person and virtual participation
Dr. Anne Marie Gannon
Health Canada
Chair, 2022 Programme Committee
On behalf of the Programme Committee, I would like to invite you to attend 54th Annual Symposium of the Society of Toxicology of Canada (STC) in our Nation’s capital, Ottawa. This is the first time since 2019 that we will be welcoming delegates and presenters in person. As we are still in the midst of the pandemic, we recognize that not all of our members may be able to attend the meeting in person, and therefore will be offering a hybrid model for this year’s meeting.
Our theme this year is “Environmental and lifestyle exposure to endocrine disrupting chemicals: from cells to society,” offering four scientific sessions focused on different aspects of endocrine disruption. The Programme Committee and the STC Board of Directors worked very hard to develop a program that includes presentations on mechanisms of toxicity of endocrine disrupting chemicals (EDCs) and more practical aspects of evaluating human health or environmental risk. Additionally, we are highlighting the impacts of EDCs on Indigenous health in an Indigenous-majority session, which will feature lectures from Indigenous community members and scientists.
I would like to thank our speakers, who will be joining us from Canada from coast-to-coast, Brazil, Denmark, and the United States, in advance for their time and commitment for preparing to speak at this year’s symposium. This program promises to deliver important insights for all toxicologists.
SCIENTIFIC PROGRAM 
DAY 1 – November 30
[ 2:00-3:30 ]
STC Board of Directors Meeting
Chair: Jayadev Raju, President STC
—
[ 4:00-5:30 pm ]
ICT-2028 Vancouver 1st Planning Meeting
Chair: Angela Hofstra, ICT-2028 Steering Committee
—
[ 5:30 pm onwards ]
Meet & Greet @ Featured Ottawa Restaurant
@ Queen Street Fare www.queenstfare.ca
Reservations made for STC guests for dinner (pay as you dine)
DAY 2 – December 1
[ 8:45 – 9:00 am ]
Welcome and Opening Remarks
Jayadev Raju, President STC
—
[ 9:00 – 10:55 am ]
SESSION I
Impacts of endocrine disrupting chemicals on Indigenous health
9:00 – 9:05 > Chair – Anne Marie Gannon, Health Canada
9:05 – 9:25 > Michelle Murphy, University of Toronto
9:25 – 10:05 > Beze Gray and Vanessa Gray, Aamjiwnaang First Nation
10:05 – 10:15 > Coffee/Tea Break
10:15 – 10:35 > Élyse Caron-Beaudoin, University of Toronto and Amira Aker, Université de Laval
10:35 – 10:55 > Laurie Chan, University of Ottawa
—
[ 10:55 – 11:15 am ]
Flash talk
Poster award finalists
—
[ 11:15 am – 12:00 pm ]
VE Henderson Award Lecture
Marc-André Verner, Université de Montréal
—
[ 1:00 – 2:55 pm ]
SESSION II
Endocrine Disruption: Considerations for Health & Consumer Product Safety
1:00-1:05 > Chair – Albert Licollari, Nucro-Technics | Co-chair – David Lefebvre, Health Canada
1:05-1:25 > Tara Barton-Maclaren, Health Canada
1:25-1:45 > Barbara Hales, McGill University
1:45-2:05 > Ella Atlas, Health Canada
2:05-2:15 > Coffee/Tea Break
2:15-2:35 > Annabelle White, Dragonfly Ventures
2:35-2:55 > David Møbjerg Kristensen, University of Copenhagen
—
[ 3:00-4:00 ]
Plenary Lecture
Endocrine Disruptors and the Developmental Origins of Breast Cancer
Dr. Ana Soto, Tufts University, USA
+ info
—
[ 4:15 – 6:15 pm ]
Trainee-Focussed Session
Chair: David Lefebvre, Health Canada
Speaker: Yad Bhuller, Health Canada
+ info
—
[ 4:15 – 6:15 pm ]
Concurrent STC Annual Business Meeting
All STC Members
—
[ 6:30 pm ]
President’s Reception and Awards Ceremony @ Lift Lounge, Delta Hotel Ottawa)
All attendees are welcome
Finger foods & refreshments provided and cash bar
DAY 3 – December 2
[ 8:30 – 10:15 am ]
SESSION III
Endocrine Disrupting Chemicals during development
8:30-8:35 > Chair – Géraldine Delbès, INRS) | Co-chair – Alison Holloway, McMaster University
8:35-8:55 > L Earl Gray, Jr., EPA
8:55-9:15 > Deborah Sloboda, McMaster University
9:15-9:25 > Hugh Taylor, Yale University
9:25-9:35 > Coffee/Tea Break
9:35-9:55 > Vicki Sutherland, NTP
9:55-10:15 > Hamid Habibi, University of Calgary
—
[ 10:15 – 11:00 am ]
Gabriel L Plaa Award Lecture
Lauren Foster, Professor Emeritus, McMaster University
—
[ 11:05 – 11:45 am ]
Short Oral Presentations
Select abstracts
—
[ 11:45 am – 1:00 pm ]
11:45 – 12:15 > Chair Yoga (optional guided practice)
12:00 – 1:00 > Lunch and Poster viewing and judging
—
[ 1:00 – 2:55 pm ]
SESSION IV
The future is now – Using NAMs to elucidate the effects of EDCs
1:00-1:05 > Chair – Angela Hofstra, Syngenta | Co-chair – Marc Beal, Health Canada
1:05-1:25 > PJ Devine, Bristol Myers Squibb
1:25-1:45 > Sandeep Raha, McMaster University
1:45-2:05 > Steve Wiseman, University of Lethbridge
2:05-2:15 > Coffee/Tea Break
2:15-2:35 > Natacha Hogan, University of Saskatchewan
2:35-2:55 > Vladimir Elias, Eurofins
—
[ 03:00 – 03:30 pm ]
Current Topic Lecture
COVID-19: the regulatory role and the science – reflections
Supriya Sharma, Health Canada
+ info
—
[ 3:30 – 3:45 pm ]
Closing Remarks
Jayadev Raju, STC President
PLENARY LECTURE
Thursday, December 1, 3:00-4:00 PM
Endocrine Disruptors and the Developmental Origins of Breast Cancer
Ana M. Soto
Tufts University, USA
Dr. Ana M. Soto is a theoretical and experimental biologist. She is a professor at Tufts University School of Medicine, Boston, and a Fellow at the Centre Cavaillès, Ecole Normale Supérieure, Paris (ENS). She was the Blaise Pascal Chair in Biology 2013-15 at the ENS. Her research interests include the control of cell proliferation, the developmental origins of cancer, endocrine disruptors and theoretical and epistemological topics pertaining to biological organization.
Dr. Soto is a co-recipient of the 2012 Gabbay Biotechnology & Medicine Award of Brandeis University, and appointed the Blaise Pascal Chair of Biology 2013-15 at the Ecole Normale Supérieure, Paris. In 2019, Dr. Soto was awarded the Grand Vermeil Medal, the highest distinction from the City of Paris for her pioneering role in the discovery of endocrine disruptors. Dr. Soto’s research profile spanning from theoretical and experimental biology to public health issues, has led to her serving as a distinguished member of government advisory panels including the US-National Academy of Sciences, the Swiss National Science Foundation, US-EPA, and EU Environmental Agency. She has also been invited to testify before multiple legislative bodies (US Congress, French Assemblée Nationale, etc).
Her research has been funded by the US National Science Foundation, the US-National Cancer Institute, the US EPA, the Susan G. Komen Foundation, the US-National Institute of Environmental Health Sciences, the Avon Foundation, the UK Medical Research Council, and EU research programs.
https://gsbs.tufts.edu/facultyResearch/faculty/soto-ana/research
TRAINEE-FOCUSSED SESSION
Thursday, December 1, 4:15-6:15 PM
Science/Education/Training/Governance & the Next Generation
Yad Bhuller
Executive Advisor
Health Canada
Since joining Health Canada, in 2002, Yad continues to lead several national and international, science-policy and regulatory initiatives. He is a strong believer in continuous education, training, and collaborative approaches to governance. As an Executive Advisor, Yad is currently pursuing an independent research opportunity to build awareness and understanding on the identification, assessment, and management of health (and environment) risks, and how this relates with next generation decision-making at Health Canada.
You can follow Yad and his leadership journey through his LinkedIn profile https://www.linkedin.com/in/
David Lefebvre
Chief, Regulatory Toxicology Research Division
Health Canada
David has a research background in food immunology, allergy, and nanotoxicology at Health Canada (HC). As the chief of the Regulatory Toxicology Research Division (Bureau of Chemical Safety, in the Food Directorate, HC), David leads an innovative research team to determine the threshold level of potential health hazards of chemical contaminants. The division also engages in initiatives federally and internationally, and provides scientific advice to support Canadian federal policies, guidelines, standards and regulations, to ensure the chemical safety of the Canadian food supply.
CURRENT TOPIC LECTURE
Friday, December 2, 3:00-3:30 PM
COVID-19: the regulatory role and the science – reflections
Supriya Sharma
Health Canada
Dr. Supriya Sharma became Health Canada’s Chief Medical Advisor in August 2015. She added these responsibilities to those in the role of Senior Medical Advisor in the Health Products and Food Branch, a role she has had since March 2013. The Health Products and Food Branch has the responsibility to regulate pharmaceuticals, medical devices, biologics, vaccines, natural health products, veterinary medicines and food. Prior to that, Dr. Sharma has held a number of positions in Health Canada over the past decade in both the pre-market and post-market health product regulatory areas including most recently Director General of the Therapeutic Products Directorate, which had the regulatory responsibility for pharmaceuticals (prescription and non-prescription) and medical devices. She has also worked as a Senior Policy Advisor as part of the National Pharmaceuticals Strategy in Health Canada. Recently, she has returned to Health Canada following a leave of absence to work in an academic research group focusing on health innovation adoption in the Canadian Health system.
Trained as a pediatrician in both Canada and Australia, Dr. Sharma was a research fellow in hematology focused on clinical research relating to thalassemia and sickle cell disease and has worked on a number of large multi-center clinical studies, including research in collaboration with Oxford University on a project in Sri Lanka. She then went on to complete a Masters of Public Health at the Harvard School of Public Health with a concentration in International Health and an interest in Health Policy.
VENUE – Delta Hotels Ottawa City Centre
101 Lyon Street, Ottawa ON
Tel: +1 613-237-3600
Website
Online Hotel Reservation NEW
Special group rate:
209 CAD – 229 CAD per night
Special group rate dates:
Sunday, November 27, 2022 to Sunday, December 4, 2022
Deadline to reserve with special group rate:
Wednesday, November 9, 2022
Visit Ottawa
The symposium venue Delta Hotel Ottawa City Centre is ideally located in downtown Ottawa, walking distance to the Parliament Hill, the ByWard Market, Museums, Rideau Canal, Shopping Centres, etc. The hotel has a dine-in restaurant, fitness room, outdoor terrace and an indoor saltwater pool.
